ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of care"

  • Abstract Number: 2226 • ACR Convergence 2025

    Factors Associated with Contraceptive Counseling by Rheumatologists for Reproductive-Aged Female Patients Prescribed Teratogenic Medications

    Yongjay Kim1, Kelsey Gripp2, Deanna Jannat-Khah3, Emily Wu4, Mehret Birru Talabi5, Nancy Pan3, Lisa Sammaritano3 and Caroline Siegel3, 1Hospital for Special Surgery, Englewood Cliffs, NJ, 2Hospital for Special Surgery, New York, 3Hospital For Special Surgery, New York, NY, 4Hospital for Special Surgery, Union City, NJ, 5University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Guidelines advise rheumatologists to provide contraceptive counseling for all patients with pregnancy potential prescribed teratogenic medications, however, adherence is inconsistent. We assessed the frequency…
  • Abstract Number: 1370 • ACR Convergence 2025

    Impact of Six-Month Monitoring Compared to Three-Month Monitoring of Labs for Methotrexate Toxicity

    Spencer Simko1, Sohini Mukherjee2, Ray Zhang2, Puneet Bajaj3 and Bonnie Bermas4, 1University of Texas Southwestern, Dallas, TX, 2University of Texas Southwestern, Dallas, 3UT Southwestern Medical Center, Dallas, TX, 4UTSouthwestern.edu, Dallas, TX

    Background/Purpose: Current rheumatology treatment guidelines recommend lab monitoring for methotrexate toxicity at three-month intervals for established patients. We sought to evaluate whether monitoring labs at…
  • Abstract Number: 0358 • ACR Convergence 2025

    Different Perspectives between Physicians and Patients on Treatment Priorities and Challenges in Still’s Disease

    Gisella Beatrice Beretta1, Luciana Pereira2, Greta Rogani3, Francesco Baldo4, Claudia Bracaglia5, Dirk Foell6, Marco Gattorno7, Marija Jelusic8, Sebastiaan Vastert3, Rashmi Sinha9 and Francesca Minoia10, 1Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Milan, Italy, 2Systemic JIA Foundation, Cincinnati, 3University Medical Center Utrecht, Utrecht, Utrecht, Netherlands, 4ASST-Pini-CTO, Milano, Milan, Italy, 5IRCCS Ospedale Pediatrico Bambino Gesu', Rome, Rome, Italy, 6University Hospital Muenster, Muenster, Germany, 7IRCCS G. Gaslini, Genova, Genoa, Italy, 8University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Zagreb, Croatia, 9Systemic JIA Foundation, Cincinnati, OH, 10Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Milan, Italy

    Background/Purpose: Despite therapeutic advances, major concerns and disparities persist in the care of Still’s Disease (SD). Capturing both patient/caregiver and physician perspectives is essential to…
  • Abstract Number: 2201 • ACR Convergence 2025

    Adherence to Reproductive Health Guidelines in Lupus Care: Insights from Patient and Physician Surveys

    Akhil Sood1, Leanna Wise2, Sadaf Sediqi1, Alyssa Howren1, Amanda Moyer1, Ellie Diamond1, Yashaar Chaichian3 and Julia F Simard4, 1Stanford University, Palo Alto, CA, 2LAGMC/Keck Medicine of USC, Los Angeles, 3Stanford University, Stanford, CA, 4Stanford Medicine, Stanford, CA

    Background/Purpose: The American College of Rheumatology has established guidelines for managing reproductive health in patients with rheumatic diseases. We assessed contraception use and counseling of…
  • Abstract Number: 1318 • ACR Convergence 2025

    Diagnostic Delay in Rheumatoid Arthritis and its Impact on Radiographic Outcomes: A Systematic Review and Meta-analysis of 100,066 Patients

    Mohamed Abdelsalam1, Menat Alla Ayman Ali Mahdy2, Bassant Elaraby Elsayed Badwy2, Maryam Lasheen3, Omar Sameh Nabil El Sedafy1, Hadeer Hafez4 and Mohamed Reda Awad5, 1Misr University For Science and Technology, 6 october, Al Jizah, Egypt, 2Misr University For Science and Technology, Nasr City, Al Qahirah, Egypt, 3Misr University For Science and Technology, Helwan, Al Qahirah, Egypt, 46th October University, 6 october, Al Jizah, Egypt, 5Al Azhar University, Cairo, Egypt, Giza, Al Jizah, Egypt

    Background/Purpose: Timely diagnosis is the cornerstone of effective rheumatoid arthritis (RA) management, with early treatment shown to significantly improve outcomes through a treat-to-target strategy. While…
  • Abstract Number: 0337 • ACR Convergence 2025

    Bridging the Bone Gap: A Quality Improvement Project on Osteoporosis Screening Practices in a Teaching Institution

    Aakanksha Pitliya1, Alexandra Georgiana Boc2, Hema Latha Anam2, Richard Oletsky2, Dipabali Chaudhuri2 and Rajesh Thirumaran2, 1Mercy Catholic Medical Center, Darby, PA, Clifton Heights, PA, 2Mercy Catholic Medical Center, Darby, PA

    Background/Purpose: Osteoporosis remains underdiagnosed despite clear guidelines. As primary care physicians and trainees are key to preventive care, this quality improvement (QI) project aimed to…
  • Abstract Number: 2195 • ACR Convergence 2025

    Enhancing MTX and LEF Safety for Immunosuppressed Women of Childbearing Age with Rheumatic Diseases

    Angela Bobak1, Rhea Sharma2, Jordan Jackson3, Maritza Nary2, Andrea Berger4, Lifang Zhang4 and Jonida Cote5, 1Geisinger Medical Center Rheumatology Fellowship, Danville, PA, 2Geisinger Medical Center Internal Medicine Residency, Danville, PA, 3Geisinger Medical Center Medicine-Pediatrics Residency, Danville, PA, 4Geisinger Health System, Danville, PA, 5Geisinger Health System, Wilkes-Barre, PA

    Background/Purpose: The rates of contraceptive counseling and treatment in immunosuppressed women of childbearing age remain low in the United States, despite ACR's Reproductive Health Guidelines…
  • Abstract Number: 1250 • ACR Convergence 2025

    Patient Perceptions of the National Tele-Rheumatology Program: A Mixed Methods Study

    Alicia Hamblin1, Catherine Nasrallah2, Cherish Wilson3, Bernard Ng4 and gabriela Schmajuk5, 1UCSF, San Francisco, CA, 2University of California San Francisco (UCSF), San Francisco, CA, 3UCSF / SFVA, San Francisco, CA, 4Lexington VA, University of Washington, Seattle, 5University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, CA

    Background/Purpose: The national shortage of rheumatology clinicians disproportionately affects over 2.7 million rural Veterans with already limited access to healthcare. To address this gap, the…
  • Abstract Number: 0231 • ACR Convergence 2025

    A Quality Improvement Project to Explore the Implications of the 2020 ACR Gout Guideline Recommendations for HLA-B5801 Testing

    Sarah Anstett1, Brian Coburn2, Carlos Garcia-Gonzalez3, Max Krall1, Akash Gupta4, Riya Madan5, Stephanie Lee6, Tania Aguila1, Adam Mayer7, Elise Breed2, Preethi Thomas8, Nora Sandorfi1, Anupama Shahane1 and Rachel Dayno1, 1University of Pennsylvania, Philadelphia, PA, 2Hospital of the University of Pennsylvania, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, 4Hospital of University of Pennsylvania, Philadelphia, PA, 5University of Pennsylvania Medical Center, Philadelphia, PA, 6University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, PA, 7University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, PA, 8UNIVERSITY OF PENNSYLVANIA, Conshohocken, PA

    Background/Purpose: The presence of the HLA-B5801 allele increases the risk of life-threatening allopurinol hypersensitivity syndrome (AHS). The 2020 ACR gout management guidelines conditionally recommend HLA-B5801…
  • Abstract Number: 2193 • ACR Convergence 2025

    Inpatient Rheumatology Consultations at a Tertiary Academic Medical Center: A Retrospective Cohort Study

    Shivang Chaudhary1, Ruizhi Huang2, Roxann Kirkwood2, Laura Upton1, Paula Buchanan2 and Adam Kilian1, 1Saint Louis University, St. Louis, MO, 2Advanced Health Data (AHEAD) Institute, St. Louis, MO

    Background/Purpose: Rheumatology consultations are essential for managing complex inpatient cases, yet patterns and outcomes remain understudied. Prior work has shown that consult data can inform…
  • Abstract Number: 1244 • ACR Convergence 2025

    PACFiND: Co-Designing Principles To Inform Reconfiguration Of Fibromyalgia Care Across Health Systems

    Rosemary Hollick1, Marcus Beasley1, Ernest Choy2, Caroline Cupit3, Debra Dulake1, Teresa Finlay3, Louise Locock1, Paul McNamee1, Catherine Pope3, Elaine Wainwright1, David Williams4 and Gary Macfarlane1, 1University of Aberdeen, Aberdeen, United Kingdom, 2Division of Infection and Immunity, CREATE Centre, Cardiff University, Cardiff, United Kingdom, 3University of Oxford, Oxford, United Kingdom, 4University of Michigan, Michigan

    Background/Purpose: Fibromyalgia is a contested and poorly supported condition, characterised by widespread pain, fatigue, and cognitive symptoms, often compounded by stigma and delayed diagnosis. Existing…
  • Abstract Number: 0230 • ACR Convergence 2025

    An Epic journey – Therapeutic Drug Monitoring at an Academic Center

    Puja Khanna1 and Michael Rice2, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Division of Gastroenterology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Non-oncologic use of immunomodulatory agents is increasing. These drugs have a narrow, patient-specific therapeutic index, making therapeutic drug monitoring essential for safe prescribing. However,…
  • Abstract Number: 2169 • ACR Convergence 2025

    Bridging the Gap: A National Needs Assessment of Rheumatology Fellowship Training in Adolescent and Young Adult Care

    Amanda Moyer1, Megha Tandel1, Michelle Benjamin1, Rufei Lu2, Julia F Simard3 and Rebecca Sadun4, 1Stanford University, Palo Alto, CA, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Stanford Medicine, Stanford, CA, 4Duke University, Durham, NC

    Background/Purpose: Adolescents and young adults (AYAs) with rheumatic diseases require specialized care, particularly when transitioning from pediatric to adult healthcare. However, most residents and fellows…
  • Abstract Number: 1143 • ACR Convergence 2025

    Gout and Renal Failure-Related Mortality Trends in USA from 1999-2020: Analysis of CDC Wonder Database

    Shiamak Cooper1, Sanjana Thimmannagari2, Ranjini Vengilote2 and Asim Khanfar2, 1Rochester General Hospital, Irondequoit, NY, 2Rochester General Hospital, Rochester, NY

    Background/Purpose: Gout is the most common form of inflammatory arthropathy, with a prevalence ranging from 0.1% to approximately 10% worldwide. Despite a well-established association between…
  • Abstract Number: 0224 • ACR Convergence 2025

    Improving Adherence to Pulmonary Hypertension Screening in Systemic Sclerosis Patients: Post-Intervention Analysis

    John Hickernell1 and Zineb Aouhab2, 1Loyola Univeristy Medical Center, Chicago, IL, 2Loyola University Medical Center, Oak Brook, IL

    Background/Purpose: Annual screening for pulmonary hypertension (PH) in patients with Systemic Sclerosis (SSc) reduces mortality. The American College of Radiology, European Society of Cardiology/European Respiratory…
  • 1
  • 2
  • 3
  • …
  • 24
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology